176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
23.74%
Net income growth under 50% of AVGO's 171.34%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-12.58%
Both reduce yoy D&A, with AVGO at -2.72%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-11.84%
Negative yoy deferred tax while AVGO stands at 450.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
5.55%
SBC growth while AVGO is negative at -1.82%. John Neff would see competitor possibly controlling share issuance more tightly.
359.79%
Slight usage while AVGO is negative at -134.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
171.43%
AR growth while AVGO is negative at -1736.36%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-195.87%
Both reduce yoy inventory, with AVGO at -102.79%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
1035.24%
AP growth well above AVGO's 326.09%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
594.86%
Growth well above AVGO's 256.60%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
213.68%
Some yoy increase while AVGO is negative at -210.71%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
146.87%
Operating cash flow growth above 1.5x AVGO's 21.34%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-73.94%
Both yoy lines negative, with AVGO at -98.95%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
244.54%
Acquisition spending well above AVGO's 94.38%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-239.68%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
66.89%
Liquidation growth of 66.89% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-150.00%
We reduce yoy other investing while AVGO is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-486.85%
We reduce yoy invests while AVGO stands at 99.39%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
63.99%
We repay more while AVGO is negative at -1100.00%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.